PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26633178-12	2015	Six courses of the gemcitabine/cisplatin chemotherapy achieved partial response of metastatic lesions, with serum neuron-specific enolase levels decreasing from 118 ng/mL to 2.6 ng/mL.	gemcitabine	19-30	enolase 2	Homo sapiens	114-137	
24137188-9	2013	NSE expression was only associated with a positive response to gemcitabine.	gemcitabine	63-74	enolase 2	Homo sapiens	0-3	
34216375-5	2021	The tumor shrank with gemcitabine/cisplatin therapy; however, neuron-specific enolase (NSE) and CYFRA levels were increased and the tumor grew.	gemcitabine	22-33	enolase 2	Homo sapiens	62-85	
34216375-5	2021	The tumor shrank with gemcitabine/cisplatin therapy; however, neuron-specific enolase (NSE) and CYFRA levels were increased and the tumor grew.	gemcitabine	22-33	enolase 2	Homo sapiens	87-90